The evolving landscape of brain metastasis
Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
PMID :
Permalink :
Title :
The evolving landscape of brain metastasis
Author(s) :
Valiente, Manuel [Auteur]
Ahluwalia, Manmeet S. [Auteur]
Boire, Adrienne [Auteur]
Brastianos, Priscilla K. [Auteur]
Goldberg, Sarah B. [Auteur]
Lee, Eudocia Q. [Auteur]
Le Rhun, Emilie [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Preusser, Matthias [Auteur]
Winkler, Frank [Auteur]
Soffietti, Riccardo [Auteur]
Ahluwalia, Manmeet S. [Auteur]
Boire, Adrienne [Auteur]
Brastianos, Priscilla K. [Auteur]
Goldberg, Sarah B. [Auteur]
Lee, Eudocia Q. [Auteur]
Le Rhun, Emilie [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Preusser, Matthias [Auteur]
Winkler, Frank [Auteur]
Soffietti, Riccardo [Auteur]
Journal title :
Trends in cancer
Abbreviated title :
Trends Cancer
Volume number :
4
Pages :
176-196
Publication date :
2018-03-01
ISSN :
2405-8025
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical ...
Show more >Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.Show less >
Show more >Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
INSERM
Université de Lille
Université de Lille
Submission date :
2022-06-15T13:57:34Z
2023-04-21T10:02:39Z
2023-04-21T10:02:39Z